People switching to Novo's Wegovy pill from obesity injections kept losing weight in real-world study - cnbc.com

As reported by CNBC

The data on Novo's Wegovy pill suggests that patients may not need to take weekly injections forever, but can instead opt for more convenient treatments.

▸ MARKET SAMACHAR VIEW

NEUTRAL

Read full article on CNBC ↗

Market Samachar is a news aggregator. This article was originally published by CNBC. Tap the button above to read the full story on their site.

INDIAN Why are world bond markets selling off again? Markets-Economic Times
INDIAN Global markets rattled as bond yields surge, offsetting AI-stock optimism Markets-Economic Times
COMPANIES Adani Group has Rs 2.6 lakh crore projects completed or under execution in Maharashtra: Pranav Adani Stocks-Markets-Economic Times
INDIAN US stocks: US markets dip as surging Treasury yields overshadow software gains Markets-Economic Times
COMPANIES Sebi revamps Document Number Verification System, adds subject matter as mandatory field Stocks-Markets-Economic Times
INDIAN UK pound falls to three-month lows as investors fret over rates, oil Markets-Economic Times
INDIAN UK 30-year gilt yields top 6% for the first time since 1998 Markets-Economic Times
INDIAN Jio Platforms IPO in final stages after concluding worldwide roadshows Markets-Economic Times

People switching to Novo's Wegovy pill from obesity injections kept losing weight in real-world study - cnbc.com

More from Market Samachar